Tag: intellectual property

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced second quarter 2025 financial results and provided a corporate update.

Continued Focus on Simplifying the Business and Accelerating Long-Term Profitable Growth
Completes Sale of PIEPS Snow Safety Brand for $9.1 Million

Second Quarter Results

Worksport Ltd. Announces August 13, 2025, as Q2 2025 Earnings Report Date

West Seneca, New York, July 31, 2025 (GLOBE NEWSWIRE) -- Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S.-based innovator and manufacturer of hybrid and clean energy solutions primarily for the light truck, overlanding, and global consumer goods markets, will report its financial results for Q2 2025 on August 13, 2025, pre-market. Steven Rossi, Chairman and CEO of the Company, will lead the call and take questions about the results.

Samsung arbitration decision and new HP license agreement drive Q2 results, exceeding outlook
Annualized recurring revenue¹, at all-time high of $553 million, up 44% YoY
Company raises full year 2025 revenue guidance by $110 million

(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, July 31, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that it will report second quarter financial results, before the US markets open on Thursday, August 7, 2025.